Effects of C-Terminal B-Chain Modifications in a Relaxin 3 Agonist Analogue.

The receptor for the neuropeptide relaxin 3, relaxin family peptide 3 (RXFP3) receptor, is an attractive pharmacological target for the control of eating, addictive, and psychiatric behaviors. Several structure-activity relationship studies on both human relaxin 3 (containing 3 disulfide bonds) and its analogue A2 (two disulfide bonds) suggest that the C-terminal carboxylic acid of the tryptophan residue in the B-chain is important for RXFP3 activity. In this study, we have added amide, alcohol, carbamate, and ester functionalities to the C-terminus of A2 and compared their structures and functions. As expected, the C-terminal amide form of A2 showed lower binding affinity for RXFP3 while ester and alcohol substitutions also demonstrated lower affinity. However, while these analogues showed slightly lower binding affinity, there was no significant difference in activation of RXFP3 compared to A2 bearing a C-terminal carboxylic acid, suggesting the binding pocket is able to accommodate additional atoms.

[1]  J. Wade,et al.  Rapid Photolysis-Mediated Folding of Disulfide-Rich Peptides. , 2019, Chemistry.

[2]  M. Kočan,et al.  Single chain peptide agonists of relaxin receptors , 2019, Molecular and Cellular Endocrinology.

[3]  Q. Kaas,et al.  Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor , 2018, The Journal of Biological Chemistry.

[4]  K. Rosengren,et al.  Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3 , 2018, The Journal of Biological Chemistry.

[5]  R. Bathgate,et al.  Challenges in the design of insulin and relaxin/insulin-like peptide mimetics. , 2017, Bioorganic & medicinal chemistry.

[6]  J. Wade,et al.  Relaxin family peptides: structure–activity relationship studies , 2017, British journal of pharmacology.

[7]  Zhan-Yun Guo,et al.  Identification of hydrophobic interactions between relaxin-3 and its receptor RXFP3: implication for a conformational change in the B-chain C-terminus during receptor binding , 2016, Amino Acids.

[8]  J. Wade,et al.  The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity , 2016, Amino Acids.

[9]  D. Craik,et al.  Solution structure, aggregation behavior, and flexibility of human relaxin-2. , 2015, ACS chemical biology.

[10]  J. Wade,et al.  Intramolecular acyl transfer in peptide and protein ligation and synthesis , 2015, Journal of peptide science : an official publication of the European Peptide Society.

[11]  A. Gundlach,et al.  Relaxin-3/RXFP3 networks: an emerging target for the treatment of depression and other neuropsychiatric diseases? , 2014, Front. Pharmacol..

[12]  J. Wade,et al.  C-Terminus of the B-Chain of Relaxin-3 Is Important for Receptor Activity , 2013, PloS one.

[13]  Quentin Kaas,et al.  Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3 , 2013, Front. Endocrin..

[14]  J. Wade,et al.  Preliminary Structure–Function Relationship Studies on Insulin-Like Peptide 5 (INSL5) , 2013, International Journal of Peptide Research and Therapeutics.

[15]  J. Wade,et al.  Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1. , 2012, Journal of medicinal chemistry.

[16]  P. Ryan,et al.  Relaxin-3 systems in the brain—The first 10 years , 2011, Journal of Chemical Neuroanatomy.

[17]  J. Wade,et al.  A simple approach for the preparation of mature human relaxin-3 , 2010, Peptides.

[18]  Jean Martínez,et al.  Synthesis of peptide alcohols on the basis of an O-N acyl-transfer reaction. , 2010, Angewandte Chemie.

[19]  J. Wade,et al.  The A-chain of Human Relaxin Family Peptides Has Distinct Roles in the Binding and Activation of the Different Relaxin Family Peptide Receptors* , 2008, Journal of Biological Chemistry.

[20]  D. Craik,et al.  Solution Structure and Novel Insights into the Determinants of the Receptor Specificity of Human Relaxin-3* , 2006, Journal of Biological Chemistry.

[21]  F. Albericio,et al.  Solid‐phase synthesis of C‐terminal modified peptides , 2004, Biopolymers.

[22]  J. Wade,et al.  Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene , 2002, The Journal of Biological Chemistry.

[23]  E. Giralt,et al.  ACTIVE CARBONATE RESINS : APPLICATION TO THE SOLID-PHASE SYNTHESIS OF ALCOHOL, CARBAMATE AND CYCLIC PEPTIDES , 1998 .

[24]  R. Summers,et al.  Relaxin family peptides and their receptors. , 2013, Physiological reviews.